JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB185655

Anti-c-Myc (phospho T58) antibody [EPR17923]

  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • What is this?

4

(1 Review)

|

(25 Publications)

Rabbit Recombinant Monoclonal C-Myc/MYC phospho T58 antibody. Suitable for Dot, WB, ICC/IF, Flow Cyt (Intra) and reacts with Synthetic peptide, Human samples. Cited in 25 publications.

View Alternative Names

BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39

6 Images
Immunocytochemistry/ Immunofluorescence - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa cells (Human epithelial cells from cervix adenocarcinoma) labeling c-Myc (phospho T58) with ab185655 at 1/250, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 (green).

Confocal image showing nuclear staining on HeLa cells. The staining decreased after blocking with phospho peptide (100μg/ml) overnight. The control peptide is a non-phospho peptide.

The nuclear counterstain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin antibody -Loading Control (ab7291) at 1/1000 dilution Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/500 (red).

The negative controls are as follows : -
-ve control 1 - ab185655 at 1/500 followed by ab150120 at 1/500.
-ve control 2 -ab7291 at 1/1000 followed by ab150077 at 1/500.

Flow Cytometry (Intracellular) - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)

Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) treated with 200nM Calyculin A and 1uM Okadaic Acid for 60 min cells labeling c-Myc with purified ab185655 at 1/700 dilution (1 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
  • WB

Supplier Data

Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)

Blocking and diluting buffer was 5% NFDM /TBST.

The strong band in Lane 1 of WB-2 compared to WB-1 is due to different lysate batches and a lower dilution factor (1 : 1000).

All lanes:

Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (ab185655) at 1/1000 dilution

Lane 1:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg

Lane 2:

HeLa (Human epithelial cell line from cervix adenocarcinoma) treated with Lambda Phosphatase whole cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 48 kDa

Observed band size: 57 kDa

true

Exposure time: 3min

Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
  • WB

Supplier Data

Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)

Blocking and diluting buffer was 5% NFDM /TBST

All lanes:

Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (ab185655) at 1/5000 dilution

Lane 1:

Untreated HeLa (Human epithelial cell line from cervix adenocarcinoma ) whole cell lysate at 10 µg

Lane 2:

HeLa (Human epithelial cell line from cervix adenocarcinoma ) treated with 200nM Calyculin A and 1uM Okadaic Acid for 60 minutes whole cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 48 kDa

Observed band size: 57 kDa

true

Exposure time: 3min

Dot Blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
  • Dot

Lab

Dot Blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)

Lane 1 : c-Myc (phospho T58).
Lane 2 : c-Myc (pT58) non-phospho peptide.
Lane 3 : c-Myc (pS62) phospho peptide.
Lane 4 : c-Myc (pS62) non-phospho peptide.

Dot blot analysis using ab185655 at a dilution of 1/1000. Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) was used as the secondary antibody at a dilution of 1/100000.

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure time : 3 minutes.

Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
  • WB

CiteAb

Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)

c-Myc (phospho T58) western blot using anti-c-Myc (phospho T58) antibody [EPR17923] ab185655. Publication image and figure legend from Kazi, A., Xiang, S., et al., 2018, Nat Commun, PubMed 30514931.

ab185655 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab185655 please see the product overview.

SB blocks the phosphorylation of β-catenin S33/S37/T41 and T58 c-Myc. a Western blots of MiaPaCa2 and A549 tumor lysates from xenografts resected from mice treated with vehicle or SB. C1, C2, and C3 are tumors from mice treated with vehicle control. SB1, SB2, and SB3 are tumors from mice treated with SB. Experiment was done once. b Western blot of MiaPaCa2 and A549 cells treated with 1 µM SB for various lengths of time. Mia designates MiaPaCa2 lysates used as positive control. Experiment was done twice

false

  • 578 PE

    PE Anti-c-Myc (phospho T58) antibody [EPR17923]

  • Carrier free

    Anti-c-Myc (phospho T58) antibody [EPR17923] - BSA and Azide free

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-c-Myc (phospho T58) antibody [EPR17923]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-c-Myc (phospho T58) antibody [EPR17923]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-c-Myc (phospho T58) antibody [EPR17923]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-c-Myc (phospho T58) antibody [EPR17923]

  • 660 APC

    APC Anti-c-Myc (phospho T58) antibody [EPR17923]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-c-Myc (phospho T58) antibody [EPR17923]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR17923

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, Dot, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/700", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "Dot-species-checked": "predicted", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "Dot-species-checked": "predicted", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Synthetic peptide": { "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/1000", "Dot-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C-Myc also known simply as Myc or MYC protein is a transcription factor with significant roles in cellular processes. Its estimated molecular weight is approximately 62 kDa. This protein is expressed in various tissues and cell types including common use in HEK (human embryonic kidney) cells for research. c-Myc functions by regulating transcription of genes involved in cell cycle progression apoptosis and cellular transformation.
Biological function summary

C-Myc is involved in regulating cell growth and proliferation. It forms part of the Myc/Max complex which binds to DNA to regulate gene expression. This activity affects cellular metabolism ribosome biogenesis and cell cycle entry emphasizing its regulation of cellular energy and stress response. Its expression levels critically govern normal cellular functions and homeostasis.

Pathways

C-Myc plays an important role in the cell cycle pathway and apoptosis regulation. Specifically c-Myc is associated with the Wnt signaling pathway which influences cellular proliferation and differentiation. It also interacts with other proteins like Cyclin D1 influencing cell cycle control. These interactions ensure c-Myc's involvement in regulating key processes related to cell proliferation and stability.

C-Myc is tightly linked to cancer such as Burkitt's lymphoma and colon cancer. In these conditions c-Myc overexpression contributes to uncontrolled cell proliferation. Additionally c-Myc is associated with other oncogenic proteins like BCL2 in tumorigenesis highlighting its pivotal role in cancer development and progression. Understanding c-Myc's involvement in these diseases aids in the development of targeted therapeutic strategies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed : 24940000, PubMed : 25956029). Activates the transcription of growth-related genes (PubMed : 24940000, PubMed : 25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed : 24940000, PubMed : 25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed : 20010808).
See full target information MYC phospho T58

Publications (25)

Recent publications for all applications. Explore the full list and refine your search

Cell communication and signaling : CCS 23:162 PubMed40176110

2025

Decursin induces FLT3-ITD acute myeloid leukemia cell apoptosis by increasing the expression of the ubiquitin-conjugase UBE2L6.

Applications

Unspecified application

Species

Unspecified reactive species

Tianxin Zhang,Yuchen Li,Wenhao Liao,Yu Mou,Xue Zhan,Qiongying Hu,Ziyi Zhao,Daqian Xiong

Molecular cell 84:4282-4296.e7 PubMed39454579

2024

Phosphorylation by JNK switches BRD4 functions.

Applications

Unspecified application

Species

Unspecified reactive species

Ballachanda N Devaiah,Amit Kumar Singh,Jie Mu,Qingrong Chen,Daoud Meerzaman,Dinah S Singer

Cellular and molecular life sciences : CMLS 81:215 PubMed38739166

2024

Prenatal treatment with preimplantation factor improves early postnatal neurogenesis and cognitive impairments in a mouse model of Down syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Manon Moreau,Rodolphe Dard,Amélia Madani,Janany Kandiah,Nadim Kassis,Jessica Ziga,Héloïse Castiglione,Solenn Day,Thomas Bourgeois,Boris Matrot,François Vialard,Nathalie Janel

Communications biology 7:541 PubMed38714838

2024

Aging-regulated PNUTS maintains endothelial barrier function via SEMA3B suppression.

Applications

Unspecified application

Species

Unspecified reactive species

Noelia Lozano-Vidal,Laura Stanicek,Diewertje I Bink,Rio P Juni,Aukie Hooglugt,Veerle Kremer,Philippa Phelp,Anke van Bergen,Alyson W MacInnes,Stefanie Dimmeler,Reinier A Boon

Plastic and reconstructive surgery 154:991-1001 PubMed37983882

2023

Knockdown of ZEB1 Inhibits Hypertrophic Scarring through Suppressing the Wnt/β-Catenin Signaling Pathway in a Mouse Model.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Jin,Zhizhong Deng,Fei Liu,Lin Lu,Feixue Ding,Yirui Shen,Hayson Chenyu Wang,Mengling Chang,Zhiyou Peng,Xiao Liang

International journal of molecular sciences 24: PubMed37762644

2023

Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Chuquan Shang,Justine Lai,Moinul Haque,Will Chen,Peng Wang,Raymond Lai

Cell death and differentiation 30:2213-2230 PubMed37726400

2023

LncRNA BCAN-AS1 stabilizes c-Myc via N-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Guandi Wu,Jiachun Su,Lingxing Zeng,Shuang Deng,Xudong Huang,Ying Ye,Rui Li,Ruihong Bai,Lisha Zhuang,Mei Li,Quanbo Zhou,Yanfen Zheng,Junge Deng,Shaoping Zhang,Rufu Chen,Dongxin Lin,Jialiang Zhang,Jian Zheng

The Journal of biological chemistry 299:105083 PubMed37495110

2023

Identification of antimycin A as a c-Myc degradation accelerator via high-throughput screening.

Applications

Unspecified application

Species

Unspecified reactive species

Ziyu Liu,Kosuke Ishikawa,Emiko Sanada,Kentaro Semba,Jiang Li,Xiaomeng Li,Hiroyuki Osada,Nobumoto Watanabe

Journal of translational medicine 21:132 PubMed36803784

2023

P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization.

Applications

Unspecified application

Species

Unspecified reactive species

Gaohong Sheng,Yuan Gao,Qing Ding,Ruizhuo Zhang,Tianqi Wang,Shaoze Jing,Hongqi Zhao,Tian Ma,Hua Wu,Yong Yang

British journal of cancer 128:1005-1018 PubMed36635500

2023

PTBP1 drives c-Myc-dependent gastric cancer progression and stemness.

Applications

Unspecified application

Species

Unspecified reactive species

Tengyang Ni,Zewen Chu,Li Tao,Yang Zhao,Miao Zhu,Yuanyuan Luo,Masataka Sunagawa,Haibo Wang,Yanqing Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com